Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease

類似資料

• A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease
  著者:: Reinisch, Walter, 等
  出版事項: (2015)
• Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
  著者:: Pollock, Richard F., 等
  出版事項: (2019)
• Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
  著者:: Aksan, Ayşegül, 等
  出版事項: (2019)
• High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23
  著者:: Dahlerup, Jens Frederik, 等
  出版事項: (2016)
• A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia
  著者:: Kalra, Philip A., 等
  出版事項: (2016)